Anti-metastasis therapy: MiRNA-134 increases the expression of TPM1 (tropomyosin) and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 30/April/2015, 18.19

Anti-metastasis therapy: MiRNA-134 increases the expression of TPM1 (tropomyosin) and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 30/April/2015, 18.19

Anti-metastasis therapy: MiRNA-134 increases the expression of TPM1 (tropomyosin) and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 30/April/2015, 18.19 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, L., Anti-metastasis therapy: MiRNA-134 increases the expression of TPM1 (tropomyosin) and inhibits migration and invasion of metastatic cancer cells via down regulation of its target gene, 30/April/2015, 18.19, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: The study presented here suggests that MiRNA-134, by decreasing the expression of its target genes, it may increase the expression of TPM1 (tropomyosin). Thereby, it may inhibit migration and invasion of metastatic cancer cells. Thus, pharmacological formulations encompassing “MiRNA-134 activators” may be used to inhibit the progression of invasive tumors.

Undisclosed information: How MiRNA-134  increases the expression of TPM1

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Molecular cancer therapy: JunB inhibits cancer development by suppressing the expression of nucleotide sanitizing enzyme MTH1/NUDT1, 26/April/2015, 17.16
Stretch therapy for pulmonary arterial hypertension: Mechanical stretch inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 1/May/2015, 9.01 am
Start Typing